2013
DOI: 10.1007/s00431-013-2217-y
|View full text |Cite
|
Sign up to set email alerts
|

Severe aortopathy due to fibulin-4 deficiency: molecular insights, surgical strategy, and a review of the literature

Abstract: Better understanding of the importance of transforming growth factor beta signaling in the pathophysiology of aortopathies such as ARCL 1B has led to targeted medical therapies. Specific surgical techniques can lead to optimal outcomes in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
25
1
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(28 citation statements)
references
References 10 publications
1
25
1
1
Order By: Relevance
“…Like the phenotypes of the knockout mice, there are notable differences in the clinical manifestations of ARCL 1A and ARCL 1B patients. A significant proportion of the patients with fibulin-4 mutations die shortly after birth or in early childhood owing to cardiopulmonary failure (Al-Hassnan et al 2012; Dasouki et al 2007; Erickson et al 2012; Hebson et al 2014; Hoyer et al 2009; Hucthagowder et al 2006; Iascone et al 2012; Kappanayil et al 2012; Renard et al 2010; Sawyer et al 2013). The common pathological findings are pulmonary emphysema, arterial tortuosity and aortic aneurysm.…”
Section: Introductionmentioning
confidence: 99%
“…Like the phenotypes of the knockout mice, there are notable differences in the clinical manifestations of ARCL 1A and ARCL 1B patients. A significant proportion of the patients with fibulin-4 mutations die shortly after birth or in early childhood owing to cardiopulmonary failure (Al-Hassnan et al 2012; Dasouki et al 2007; Erickson et al 2012; Hebson et al 2014; Hoyer et al 2009; Hucthagowder et al 2006; Iascone et al 2012; Kappanayil et al 2012; Renard et al 2010; Sawyer et al 2013). The common pathological findings are pulmonary emphysema, arterial tortuosity and aortic aneurysm.…”
Section: Introductionmentioning
confidence: 99%
“…A total of 12 distinct FBLN4 pathogenic mutations have been reported thus far (3,4,(15)(16)(17)(18)(19)(20)(21)(22). The mutations fall into two groups: nine missense and three frameshift mutations.…”
mentioning
confidence: 99%
“…In humans or mouse models with arterial tortuosity syndrome (Cheng et al, 2009; Coucke et al, 2006), Loeys-Dietz syndrome (Gallo et al, 2014; Loeys et al, 2006), Marfan syndrome (Morris et al, 2011), with mutations in genes of the TGFÎČ signaling pathway [ SMAD3 (van de Laar et al, 2011, 2012), TGFB2 (Lindsay et al, 2012), PRKG1 (Guo et al, 2013)] or with mutations in genes directly involved in elastogenesis [ EFEMP2 (Hebson et al, 2014), Fbln5 (Nakamura et al, 2002; Yanagisawa et al, 2002), Ltbp4 (Bultmann-Mellin et al, 2015), Eln (Wagenseil et al, 2009)], aortic or arterial tortuosity is a commonly described feature. Increased aortic tortuosity is associated with a poorer prognosis in aortic diseases (Franken et al, 2015; Hatakeyama et al, 2001; Morris et al, 2011; Shirali et al, 2013), but the detailed mechanisms leading to tortuosity are still unknown (Morris, 2015).…”
Section: Discussionmentioning
confidence: 99%